Desialylation of platelets induced by Von Willebrand Factor is a novel mechanism of platelet clearance in dengue

PLoS Pathog. 2019 Mar 8;15(3):e1007500. doi: 10.1371/journal.ppat.1007500. eCollection 2019 Mar.

Abstract

Thrombocytopenia and platelet dysfunction are commonly observed in patients with dengue virus (DENV) infection and may contribute to complications such as bleeding and plasma leakage. The etiology of dengue-associated thrombocytopenia is multifactorial and includes increased platelet clearance. The binding of the coagulation protein von Willebrand factor (VWF) to the platelet membrane and removal of sialic acid (desialylation) are two well-known mechanisms of platelet clearance, but whether these conditions also contribute to thrombocytopenia in dengue infection is unknown. In two observational cohort studies in Bandung and Jepara, Indonesia, we show that adult patients with dengue not only had higher plasma concentrations of plasma VWF antigen and active VWF, but that circulating platelets had also bound more VWF to their membrane. The amount of platelet-VWF binding correlated well with platelet count. Furthermore, sialic acid levels in dengue patients were significantly reduced as assessed by the binding of Sambucus nigra lectin (SNA) and Maackia amurensis lectin II (MAL-II) to platelets. Sialic acid on the platelet membrane is neuraminidase-labile, but dengue virus has no known neuraminidase activity. Indeed, no detectable activity of neuraminidase was present in plasma of dengue patients and no desialylation was found of plasma transferrin. Platelet sialylation was also not altered by in vitro exposure of platelets to DENV nonstructural protein 1 or cultured DENV. In contrast, induction of binding of VWF to glycoprotein 1b on platelets using the VWF-activating protein ristocetin resulted in the removal of platelet sialic acid by translocation of platelet neuraminidase to the platelet surface. The neuraminidase inhibitor oseltamivir reduced VWF-induced platelet desialylation. Our data demonstrate that excessive binding of VWF to platelets in dengue results in neuraminidase-mediated platelet desialylation and platelet clearance. Oseltamivir might be a novel treatment option for severe thrombocytopenia in dengue infection.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Blood Coagulation Factors
  • Blood Platelets / metabolism*
  • Blood Platelets / physiology
  • Cohort Studies
  • Dengue / metabolism
  • Female
  • Fibrinogen
  • Humans
  • Indonesia
  • Kinetics
  • Male
  • Myelin and Lymphocyte-Associated Proteolipid Proteins
  • N-Acetylneuraminic Acid / metabolism*
  • Neuraminidase / metabolism
  • Plant Lectins
  • Platelet Membrane Glycoproteins / metabolism
  • Ribosome Inactivating Proteins
  • Thrombocytopenia
  • Young Adult
  • von Willebrand Factor / metabolism
  • von Willebrand Factor / physiology*

Substances

  • Blood Coagulation Factors
  • MAL2 protein, human
  • Myelin and Lymphocyte-Associated Proteolipid Proteins
  • Plant Lectins
  • Platelet Membrane Glycoproteins
  • Sambucus nigra lectins
  • von Willebrand Factor
  • Fibrinogen
  • Neuraminidase
  • Ribosome Inactivating Proteins
  • N-Acetylneuraminic Acid

Grants and funding

This project was financially supported by ZonMW (grant 451001005). V.K. is funded by the Netherlands Fellowship Program. R.N.T. was funded by the DIKTI-NESO Ph.D. Fellowship from the Indonesian Ministry of Education and Culture. S.F.R. is supported by a grant from the Indonesia Education Scholarship from The Indonesia Endowment Fund for Education (LPDP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.